Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease

NCT01410500 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib

Sponsor

Amgen

Collaborators

[object Object]